Previous close | 5.18 |
Open | 5.20 |
Bid | 5.28 x 100 |
Ask | 5.34 x 100 |
Day's range | 5.14 - 5.47 |
52-week range | 1.04 - 11.20 |
Volume | |
Avg. volume | 221,914 |
Market cap | 261.642M |
Beta (5Y monthly) | 2.75 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.14 |
Earnings date | 02 May 2024 - 06 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 5.63 |
MENLO PARK, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients' lives, today announced it will present at the upcoming 23rd Annual Needham Healthcare Conference being held virtually. Sight Sciences’ management is scheduled to present on Tuesday, April 9, 2024, at 12:45 pm PT
Sight Sciences, Inc. (NASDAQ:SGHT) Q4 2023 Earnings Call Transcript March 7, 2024 Sight Sciences, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, thank you for standing by and welcome to the Sight Sciences Fourth Quarter 2023 […]
Q4 2023 Sight Sciences Inc Earnings Call